Screener
Eligibility screening
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
3 US sites in SC, TX, VA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.